- Home
- ONTO vs RVNC Comparison
ONTO vs RVNC Comparison
Compare ONTO & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONTO
- RVNC
- Stock Information
- Founded
- ONTO 1940
- RVNC 1999
- Country
- ONTO United States
- RVNC United States
- Employees
- ONTO N/A
- RVNC N/A
- Industry
- ONTO Industrial Machinery/Components
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- ONTO Industrials
- RVNC Health Care
- Exchange
- ONTO Nasdaq
- RVNC Nasdaq
- Market Cap
- ONTO 8.0B
- RVNC 320.5M
- IPO Year
- ONTO N/A
- RVNC 2014
- Fundamental
- Price
- ONTO $167.30
- RVNC $3.09
- Analyst Decision
- ONTO Strong Buy
- RVNC Hold
- Analyst Count
- ONTO 8
- RVNC 9
- Target Price
- ONTO $254.29
- RVNC $8.45
- AVG Volume (30 Days)
- ONTO 756.1K
- RVNC 3.6M
- Earning Date
- ONTO 02-06-2025
- RVNC 11-07-2024
- Dividend Yield
- ONTO N/A
- RVNC N/A
- EPS Growth
- ONTO 16.27
- RVNC N/A
- EPS
- ONTO 3.70
- RVNC N/A
- Revenue
- ONTO $942,238,000.00
- RVNC $256,945,000.00
- Revenue This Year
- ONTO $23.06
- RVNC $11.28
- Revenue Next Year
- ONTO $16.73
- RVNC $27.21
- P/E Ratio
- ONTO $45.19
- RVNC N/A
- Revenue Growth
- ONTO 10.81
- RVNC 25.82
- 52 Week Low
- ONTO $134.11
- RVNC $2.30
- 52 Week High
- ONTO $238.93
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- ONTO 45.31
- RVNC 33.47
- Support Level
- ONTO $163.45
- RVNC $3.06
- Resistance Level
- ONTO $182.34
- RVNC $3.09
- Average True Range (ATR)
- ONTO 6.04
- RVNC 0.11
- MACD
- ONTO 1.14
- RVNC 0.02
- Stochastic Oscillator
- ONTO 26.71
- RVNC 6.90
About ONTO Onto Innovation Inc.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the largest sources of total revenue.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.